| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.29 | 0.08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |